Pfizer recalls Nurtec ODT 75 mg tablets, packaging not child-resistant


Well-Known Member
Aug 29, 2022
Reaction score

Recall Details​


This recall involves prescription drugs Nurtec ODT 75 mg orally disintegrating tablets sold in cartons containing one blister card of 8 tablets. The tablets are in a non-child resistant blister card packaged in a carton that includes the name of the product, dosage strength, NDC number and expiration date. The dosage strength and expiration date are printed or stamped on the blister card.
The recall includes the following:

Product Description

NDC Number

Expiration Date

Nurtec® ODT (rimegepant) 75mg 8-Unit Dose blister pack


All dates through 6/2026

Consumers should immediately secure the recalled product out of the sight and reach of children and contact Pfizer for a free child resistant pouch to store the product. Once the product is secured, consumers can continue to use it as directed.


None reported

Sold At:
Pharmacies nationwide as a prescribed medicine from December 2021 through March 2023. The prices of the product varied based on health insurance terms and other factors.

Biohaven Pharmaceuticals Inc., of New Haven, Conn. and Pfizer Inc., of New York

Manufactured In:

United States

Recall number:

Consumer Contact

Pfizer at 800-879-3477 Monday through Friday 9 a.m. to 7 p.m. ET, online at or online at or and click “Recall to provide child resistant pouches to patients for storage of their medicine. Click for details” for more information.